Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Misako Matsumoto

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Cancer Immunology, Immunotherapy : CII|February 3, 2009
The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancerTsukasa Seya, Misako Matsumoto
The International Journal of Biochemistry & Cell Biology|May 15, 2002
A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2Tsukasa Seya, Misako Matsumoto
Seikagaku. the Journal of Japanese Biochemical Society|April 22, 2009
[Role of Toll-like receptors in innate and adaptive immune responses]Misako Matsumoto, Tsukasa Seya
Advanced Drug Delivery Reviews|February 12, 2008
TLR3: interferon induction by double-stranded RNA including poly(I:C)Misako Matsumoto, Tsukasa Seya
Oncoimmunology|April 9, 2016
Tumor vaccines with dsRNA adjuvant ARNAX induces antigen-specific tumor shrinkage without cytokinemiaTsukasa Seya, Yohei Takeda, Misako Matsumoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2015
[Chronic hepatitis C virus infection attenuates host antiviral innate immune response]Hiroyuki Oshiumi, Misako Matsumoto, Tsukasa Seya
Uirusu|September 29, 2004
[Toll-like receptors that sense viral infection]Tsukasa Seya, Masashi Shingai, Misako Matsumoto
Cells|December 23, 2022
Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune EnhancementTsukasa Seya, Megumi Tatematsu, Misako Matsumoto
Reviews in Medical Virology|February 12, 2011
Antiviral responses induced by the TLR3 pathwayMisako Matsumoto, Hiroyuki Oshiumi, Tsukasa Seya
Uirusu|January 6, 2009
HCV and innate immunityTakashi Ebihara, Misako Matsumoto, Tsukasa Seya
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Cancer Immunology, Immunotherapy : CII|February 3, 2009
The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancerTsukasa Seya, Misako Matsumoto
The International Journal of Biochemistry & Cell Biology|May 15, 2002
A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2Tsukasa Seya, Misako Matsumoto
Seikagaku. the Journal of Japanese Biochemical Society|April 22, 2009
[Role of Toll-like receptors in innate and adaptive immune responses]Misako Matsumoto, Tsukasa Seya
Advanced Drug Delivery Reviews|February 12, 2008
TLR3: interferon induction by double-stranded RNA including poly(I:C)Misako Matsumoto, Tsukasa Seya
Oncoimmunology|April 9, 2016
Tumor vaccines with dsRNA adjuvant ARNAX induces antigen-specific tumor shrinkage without cytokinemiaTsukasa Seya, Yohei Takeda, Misako Matsumoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2015
[Chronic hepatitis C virus infection attenuates host antiviral innate immune response]Hiroyuki Oshiumi, Misako Matsumoto, Tsukasa Seya
Uirusu|September 29, 2004
[Toll-like receptors that sense viral infection]Tsukasa Seya, Masashi Shingai, Misako Matsumoto
Cells|December 23, 2022
Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune EnhancementTsukasa Seya, Megumi Tatematsu, Misako Matsumoto
Reviews in Medical Virology|February 12, 2011
Antiviral responses induced by the TLR3 pathwayMisako Matsumoto, Hiroyuki Oshiumi, Tsukasa Seya
Uirusu|January 6, 2009
HCV and innate immunityTakashi Ebihara, Misako Matsumoto, Tsukasa Seya
Pageof 21